AI/ML INNOVATIONS INC. · CSE: AIML

One Company. Three Markets. One Engine.

AIML is the publicly traded company behind Neural Cloud Solutions — the operating business whose patented cardiac-AI engine serves three markets: regulated ECG monitoring, consumer wearables, and cardiac safety in clinical research.

Explore Our Company

See the Investment Case

Latest from AIML

Press Release

September 1, 2026

AI/ML Innovations subsidiary NeuralCloud Appoints Former FDA Reviewer Dr. Mehmet Kosoglu as the Head of Regulatory Affairs

Read the announcement

Newsletter

September 9, 2026

"The Pulse" June 2026, The Latest from AI/ML Innovations Inc.

Learn more

Opens in a new tab

ONE ENGINE. THREE MARKETS.

Neural Cloud's patented engine, serving three markets.

AI/ML Innovations is the publicly traded company behind Neural Cloud Solutions — the single operating business that owns the products, the IP, and the go-to-market. One cardiac-AI engine, deployed across three markets.

NC

The operating business & patented engine.

Neural Cloud Solutions

The Operating Business

Neural Cloud owns the products — MaxYield™, CardioYield™, BodyOS™ — plus the IP and the go-to-market. Its patented cardiac-AI engine is the single platform behind everything AIML builds.

Visit NeuralCloud.com

R

Regulated — ECG patch & Holter monitoring.

Regulated Market

ECG Patch & Holter Monitoring

The core clinical market: AI-assisted ECG analysis for regulated patch and Holter monitoring. $6.4B today, estimated to grow to $11.3B by 2032 (6.1% CAGR).

$11.3B by 2032

citation

N

Non-Regulated — consumer wearable technology.

Non-Regulated Market

Consumer Wearable Technology

The same engine applied to consumer wearables and RPM — everyday and performance cardiac insight. $82.3B in 2024, estimated to grow to $230.2B by 2032 (12.1% CAGR).

$230.2B by 2032

citation

C

Clinical Research — cardiac safety in trials.

Clinical Research Market

Cardiac Safety in Clinical Trials

High-fidelity, expert-validated ECG analysis for cardiac safety in clinical trials — a defensible, data-rich market. $1.06B in 2025, estimated to grow to $2.34B by 2032 (11.9% CAGR).

$2.34B by 2032

citation

Two of the world's most published cardiac electrophysiologists co-develop the algorithm and personally label the Neural Edge dataset.

MEDICAL ADVISORY BOARD

Built under world-class clinical guidance.

Our technology is developed and validated under the direct guidance of two of the world's most published cardiac electrophysiologists — who don't just advise. They actively lead product development and personally label our proprietary dataset.

Dr. Paul Dorian - 600+ peer-reviewed publications, Professor of Medicine, University of Toronto, Head of the Medical Advisory Board

Dr. Martin Green - a founding figure of Canadian cardiac electrophysiology and KOL dataset annotator.

Meet the full advisory board

ONE ENGINE. THREE MARKETS.

Neural Cloud's patented engine, serving three markets.

AI/ML Innovations is the publicly traded company behind Neural Cloud Solutions — the single operating business that owns the products, the IP, and the go-to-market. One cardiac-AI engine, deployed across three markets.

Metric 01

3

Markets served by Neural Cloud's single cardiac-AI engine.

Metric 02

<1

ms

Per-beat PQRST detection through Neural Cloud's MaxYield engine.

Metric 03

3–5

×

Higher overread throughput with AI-assisted ECG analysis.

Metric 04

1B

+

Heartbeats processed by MaxYield ECG neural network.

Featured this week

The latest from AI/ML Innovations.

All press releases

Press Release

September 1, 2026

AI/ML Innovations subsidiary NeuralCloud Appoints Former FDA Reviewer Dr. Mehmet Kosoglu as the Head of Regulatory Affairs

Regulatory Executive Brings More Than 15 Years of FDA, Medical Device, SaMD, and Digital Health Experience to Support AIML’s Medical Device Strategy

Learn more

PRESS RELEASE

August 26, 2026

AI/ML Innovations Inc. Closes First Tranche of Private Placement

Learn more

PRESS RELEASE

August 18, 2026

AIML Subsidiary NeuralCloud Signs Term Sheet with Island Mobile Cardiology Testing for CardioYield™ Pilot

Learn more

PRESS RELEASE

August 14, 2026

AI/ML Innovations Inc. Announces Proposed Private Placement

Learn more

THE NEURAL CLOUD ENGINE

The engine that gets stronger with every rotation.

MaxYield's patented engine processes cardiac signal and deploys across three markets — regulated ECG monitoring, consumer wearables, and cardiac safety in clinical research. Every deployment feeds validated signal back to the engine, and every improvement wins more of each market. The flywheel is self-reinforcing — and it compounds.

“One engine. Three markets. Every rotation makes the whole system stronger.”

Regulated ECG patch & Holter

Non-Regulated Consumer wearables

Clinical Research Cardiac safety in trials

One Company. Three Markets. One Engine.

Neural Cloud's patented engine, serving three markets.

The operating business & patented engine.

The Operating Business

Regulated — ECG patch & Holter monitoring.

ECG Patch & Holter Monitoring

Non-Regulated — consumer wearable technology.

Consumer Wearable Technology

Clinical Research — cardiac safety in trials.

Cardiac Safety in Clinical Trials

Built under world-class clinical guidance.

Neural Cloud's patented engine, serving three markets.

The latest from AI/ML Innovations.

Every channel. One feed.

The engine that gets stronger with every rotation.

Where technology meets human potential.

Signal, not noise, from the front line of cardiac AI.